See more : Cosmo Pharmaceuticals N.V. (COPN.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Kunming Chuan Jin Nuo Chemical Co., Ltd. (300505.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kunming Chuan Jin Nuo Chemical Co., Ltd., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
You may be interested
- Empresa Nacional de Telecomunicaciones S.A. (ENTEL.SN) Income Statement Analysis – Financial Results
- Beijing Energy International Holding Co., Ltd. (PVLTF) Income Statement Analysis – Financial Results
- VirTra, Inc. (VTSI) Income Statement Analysis – Financial Results
- DNO ASA (DTNOF) Income Statement Analysis – Financial Results
- Park National Corporation (PRK) Income Statement Analysis – Financial Results
Kunming Chuan Jin Nuo Chemical Co., Ltd. (300505.SZ)
About Kunming Chuan Jin Nuo Chemical Co., Ltd.
Kunming Chuan Jin Nuo Chemical Co., Ltd. produces and sells phosphate products in China. Its products include feed grade phosphate, fertilizer grade phosphate, and industrial grade phosphoric acid and fine phosphates, as well as iron concentrate powder. The company was founded in 2005 and is based in Kunming, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.71B | 2.52B | 1.54B | 1.05B | 1.13B | 965.59M | 799.81M | 646.80M | 545.96M | 460.01M | 533.14M | 478.46M | 336.59M | 229.78M | 179.02M |
| Cost of Revenue | 2.68B | 1.99B | 1.22B | 940.66M | 811.37M | 680.07M | 548.28M | 420.04M | 365.27M | 307.76M | 361.91M | 318.49M | 214.11M | 141.99M | 103.35M |
| Gross Profit | 33.31M | 525.19M | 316.19M | 109.15M | 314.62M | 285.52M | 251.54M | 226.76M | 180.68M | 152.26M | 171.22M | 159.97M | 122.48M | 87.79M | 75.67M |
| Gross Profit Ratio | 1.23% | 20.84% | 20.59% | 10.40% | 27.94% | 29.57% | 31.45% | 35.06% | 33.09% | 33.10% | 32.12% | 33.43% | 36.39% | 38.21% | 42.27% |
| Research & Development | 42.62M | 9.74M | 3.25M | 2.54M | 3.35M | 2.40M | 1.53M | 13.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 42.58M | 17.51M | 16.34M | 4.93M | 5.73M | 5.32M | 3.91M | 3.19M | 3.00M | 3.15M | 2.97M | 26.43M | 14.89M | 5.87M | 4.67M |
| Selling & Marketing | 9.43M | 32.02M | 14.47M | 9.13M | 176.33M | 165.62M | 130.13M | 121.77M | 93.15M | 76.00M | 76.87M | 62.17M | 52.65M | 41.93M | 37.41M |
| SG&A | 52.01M | 49.53M | 30.81M | 14.06M | 182.06M | 170.94M | 134.04M | 124.95M | 96.16M | 79.15M | 79.85M | 88.60M | 67.54M | 47.80M | 42.08M |
| Other Expenses | 0.00 | 3.81M | 1.48M | 200.74K | 1.63M | -1.28M | 100.86K | 5.87M | 651.41K | 11.65M | 19.71M | 2.52M | 4.57M | 539.01K | -285.57K |
| Operating Expenses | 189.39M | 96.93M | 76.24M | 50.70M | 223.00M | 199.95M | 168.41M | 162.89M | 120.44M | 99.18M | 99.08M | 88.93M | 67.70M | 47.90M | 42.09M |
| Cost & Expenses | 2.85B | 2.09B | 1.30B | 991.36M | 1.03B | 880.02M | 716.68M | 582.93M | 485.72M | 406.93M | 460.99M | 407.42M | 281.81M | 189.89M | 145.43M |
| Interest Income | 5.17M | 661.22K | 692.65K | 519.93K | 350.98K | 211.79K | 273.31K | 381.08K | 95.23K | 123.44K | 222.66K | -0.50 | -0.76 | 0.00 | -0.99 |
| Interest Expense | 38.20M | 16.62M | 16.82M | 9.46M | 6.42M | 8.08M | 5.68M | 5.74M | 7.49M | 7.54M | 6.54M | 3.14M | 2.40M | 1.32M | 220.72K |
| Depreciation & Amortization | 132.33M | 115.86M | 86.60M | 61.75M | 58.25M | 44.00M | 36.74M | 34.53M | 31.33M | 26.55M | 22.27M | 16.20M | 12.17M | 9.65M | 5.73M |
| EBITDA | 34.07M | 548.69M | 327.10M | 121.23M | 150.89M | 128.28M | 114.45M | 109.57M | 88.51M | 78.66M | 90.23M | 87.24M | 66.94M | 49.54M | 39.31M |
| EBITDA Ratio | 1.26% | 21.70% | 21.35% | 11.33% | 13.79% | 13.13% | 14.57% | 17.02% | 16.90% | 18.24% | 20.25% | 14.89% | 16.33% | 21.66% | 22.08% |
| Operating Income | -113.75M | 409.18M | 221.82M | 49.13M | 84.28M | 77.22M | 71.92M | 63.53M | 49.76M | 44.66M | 65.19M | 68.16M | 52.44M | 38.66M | 33.15M |
| Operating Income Ratio | -4.20% | 16.24% | 14.44% | 4.68% | 7.48% | 8.00% | 8.99% | 9.82% | 9.11% | 9.71% | 12.23% | 14.25% | 15.58% | 16.82% | 18.52% |
| Total Other Income/Expenses | -19.52M | 3.81M | -16.42M | -11.04M | -5.41M | -1.28M | -4.57M | 5.70M | -6.77M | -3.27M | 9.72M | 2.50M | 4.29M | 223.75K | -285.57K |
| Income Before Tax | -133.27M | 412.99M | 223.31M | 49.33M | 85.91M | 75.94M | 72.02M | 69.25M | 50.41M | 48.85M | 78.56M | 70.66M | 56.73M | 38.88M | 32.86M |
| Income Before Tax Ratio | -4.92% | 16.39% | 14.54% | 4.70% | 7.63% | 7.86% | 9.01% | 10.71% | 9.23% | 10.62% | 14.74% | 14.77% | 16.85% | 16.92% | 18.36% |
| Income Tax Expense | -34.81M | 50.89M | 29.23M | 8.02M | 13.10M | 11.83M | 11.44M | 11.17M | 8.21M | 8.07M | 20.74M | 17.84M | 14.43M | 9.84M | 8.41M |
| Net Income | -91.46M | 347.04M | 189.06M | 41.48M | 72.81M | 64.11M | 60.58M | 58.09M | 42.20M | 40.77M | 57.83M | 52.81M | 42.30M | 29.04M | 24.45M |
| Net Income Ratio | -3.37% | 13.77% | 12.31% | 3.95% | 6.47% | 6.64% | 7.57% | 8.98% | 7.73% | 8.86% | 10.85% | 11.04% | 12.57% | 12.64% | 13.66% |
| EPS | -0.37 | 1.54 | 0.94 | 0.21 | 0.37 | 0.35 | 0.33 | 0.34 | 0.31 | 0.30 | 0.45 | 0.38 | 0.33 | 0.00 | 0.00 |
| EPS Diluted | -0.37 | 1.54 | 0.94 | 0.21 | 0.37 | 0.35 | 0.33 | 0.34 | 0.31 | 0.30 | 0.45 | 0.38 | 0.33 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 245.59M | 224.69M | 200.29M | 196.03M | 196.03M | 182.05M | 182.05M | 170.66M | 136.53M | 137.08M | 136.22M | 137.31M | 126.90M | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 245.59M | 224.69M | 200.29M | 196.03M | 196.03M | 182.06M | 182.05M | 170.66M | 136.53M | 137.08M | 136.22M | 137.31M | 126.90M | 0.00 | 0.00 |
No news found for: 300505.SZ
Source: https://incomestatements.info
Category: Stock Reports